Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction

NCT07615023 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT07615023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07615023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Recruiting
Start date
June 20, 2026
Completion date
June 20, 2030
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clonal hematopoiesis of indeterminate potential (chip), st-elevation myocardial infarction (stemi)